Development of a bacterial detection assay for point-of-care infection monitoring
Ineffective diagnosis of bacterial infections leads to excess healthcare costs of $25
billion/year worldwide due to transmission of infections while waiting for diagnosis,
unnecessary antibiotic treatments and resulting increased drug resistance, etc. Point-of-care
molecular testing can help provide timely and effective diagnoses leading to better (and more
cost-effective) patient management. Markets where point-of-care testing would make a large
difference are the hospital-acquired infections markets, sexually transmitted infection (STI)
market, and upper respiratory infections market.
This proposal will marry a unique bacterial detection strategy with a multiplexed chip-based
device for rapid analysis of infectious pathogens. The applicant, Dr. Das, has developed a
strategy that allows trace quantities of bacteria to be analyzed in 30 minutes or less. In the
proposed project, he will test whether it can be run on a multiplexed chip and whether the
resulting assay will be practical for use in a point-of-care testing system. The sponsor,
Xagenic (Canada) Inc., will benefit from this effort as it will speed the….
View Full Project DescriptionShana Kelley
Xagenic Inc
Life Sciences
University of Toronto
Accelerate